| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:10:01 UTC |
|---|
| Update date | 2020-09-17 15:41:35 UTC |
|---|
| Primary ID | FDB012163 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Dopamine |
|---|
| Description | Dopamine, also known as 3-hydroxytyramine or deoxyepinephrine, belongs to the class of organic compounds known as catecholamines and derivatives. Catecholamines and derivatives are compounds containing 4-(2-Aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] or a derivative thereof formed by substitution. Dopamine is a drug which is used for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure. Dopamine is a very strong basic compound (based on its pKa). Dopamine exists in all living organisms, ranging from bacteria to humans. Within humans, dopamine participates in a number of enzymatic reactions. In particular, dopamine can be biosynthesized from tyramine; which is catalyzed by the enzyme tyrosinase. In addition, dopamine and ascorbic acid can be converted into norepinephrine and dehydroascorbic acid; which is mediated by the enzyme dopamine beta-hydroxylase. Catechol in which the hydrogen at position 4 is substituted by a 2-aminoethyl group. In humans, dopamine is involved in disulfiram action pathway. Outside of the human body, Dopamine is found, on average, in the highest concentration within a few different foods, such as swiss chards, oats, and red beetroots and in a lower concentration in green zucchinis, broccoli, and yellow bell peppers. Dopamine has also been detected, but not quantified in, several different foods, such as potato, banana, avocado, eggplants, and custard apples. This could make dopamine a potential biomarker for the consumption of these foods. Dopamine is a potentially toxic compound. Dopamine, with regard to humans, has been found to be associated with several diseases such as bacterial meningitis, eosinophilic esophagitis, cerebral infarction, and schizophrenia; dopamine has also been linked to the inborn metabolic disorder aromatic l-amino acid decarboxylase deficiency. |
|---|
| CAS Number | 62-31-7 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 2-(3,4-Dihydroxyphenyl)ethylamine | ChEBI | | 3,4-Dihydroxyphenethylamine | ChEBI | | 3-Hydroxytyramine | ChEBI | | 4-(2-Aminoethyl)-1,2-benzenediol | ChEBI | | 4-(2-Aminoethyl)benzene-1,2-diol | ChEBI | | 4-(2-Aminoethyl)catechol | ChEBI | | 4-(2-Aminoethyl)pyrocatechol | ChEBI | | Deoxyepinephrine | ChEBI | | Dopamina | ChEBI | | Dopaminum | ChEBI | | Hydroxytyramin | ChEBI | | Medopa | Kegg | | 3,4-Dihydroxyphenylethylamine | HMDB | | 4-(2-Aminoethyl)-pyrocatechol | HMDB | | a-(3,4-Dihydroxyphenyl)-b-aminoethane | HMDB | | alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane | HMDB | | Dopamin | HMDB | | Dopastat | HMDB | | Dophamine | HMDB | | Dynatra | HMDB | | Hydroxytyramine | HMDB | | Intropin | HMDB | | Oxytyramine | HMDB | | Revivan | HMDB | | 3,4 Dihydroxyphenethylamine | HMDB | | Hydrochloride, dopamine | HMDB | | Dopamine hydrochloride | HMDB | | (3H)-Dopamine | biospider | | 1,2-Benzenediol, 4-(2-aminoethyl)- (9CI) | biospider | | 3-Hydroxtyramine | biospider | | 4-(2-Aminoethyl)-1,2-benzenediol, 9CI | db_source | | 4-(2-aminoethyl)benzene-1,2-diol | biospider | | ASL 279 | db_source | | Cardiosteril | db_source | | NSC 169105 | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C8H11NO2 |
|---|
| IUPAC name | 4-(2-aminoethyl)benzene-1,2-diol |
|---|
| InChI Identifier | InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2 |
|---|
| InChI Key | VYFYYTLLBUKUHU-UHFFFAOYSA-N |
|---|
| Isomeric SMILES | NCCC1=CC(O)=C(O)C=C1 |
|---|
| Average Molecular Weight | 153.1784 |
|---|
| Monoisotopic Molecular Weight | 153.078978601 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as catecholamines and derivatives. Catecholamines and derivatives are compounds containing 4-(2-Aminoethyl)pyrocatechol [4-(2-aminoethyl)benzene-1,2-diol] or a derivative thereof formed by substitution. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Phenols |
|---|
| Sub Class | Benzenediols |
|---|
| Direct Parent | Catecholamines and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Catecholamine
- Phenethylamine
- 2-arylethylamine
- 1-hydroxy-4-unsubstituted benzenoid
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Monocyclic benzene moiety
- Amine
- Hydrocarbon derivative
- Primary amine
- Organopnictogen compound
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organic oxygen compound
- Organic nitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Indirect biological role: Industrial application: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 62.73%; H 7.24%; N 9.14%; O 20.89% | DFC |
|---|
| Melting Point | 128 oC | |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | -0.98 | HANSCH,C ET AL. (1995) |
|---|
| Experimental pKa | 8.93 | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | +1 | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| EI-MS | Mass Spectrum (Electron Ionization) | splash10-00e9-8900000000-88acdc978fe4a64e0fc5 | 2014-09-20 | View Spectrum | | GC-MS | Dopamine, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-117a1a7207245f5377e7 | Spectrum | | GC-MS | Dopamine, 4 TMS, GC-MS Spectrum | splash10-00di-1900000000-8b7dcae82868308513da | Spectrum | | GC-MS | Dopamine, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-117a1a7207245f5377e7 | Spectrum | | GC-MS | Dopamine, non-derivatized, GC-MS Spectrum | splash10-00di-1900000000-8b7dcae82868308513da | Spectrum | | Predicted GC-MS | Dopamine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-001i-8900000000-752bc8c11fa321b8a7ac | Spectrum | | Predicted GC-MS | Dopamine, 2 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-0089-9280000000-c894c19dda88ac048dd4 | Spectrum | | Predicted GC-MS | Dopamine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_2_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TMS_2_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_2_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_2_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Dopamine, TBDMS_2_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-0uxu-4900000000-ff51177ebcb89b8c956c | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-0006-9200000000-a554eb700a06cecb8292 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-014l-9000000000-db9813e1025f237a549b | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-0udi-0900000000-27e0d71db6d14d79759c | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-0uk9-0900000000-f1cf97c0d0dd509e229e | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-00di-0900000000-aa09a2411e287abe74ed | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative | splash10-00di-1900000000-97c42b109cab2005373d | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative | splash10-006x-9700000000-974bd18febffcceea2d6 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-0f79-0900000000-099173d4201beca9e548 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-000i-1900000000-9dc09f2661247c9d84b0 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-0006-9300000000-8b85fa9aac1ffb4c2873 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-0006-9000000000-9ea16d2057010279d433 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014l-9000000000-32ca2db8fe2b4729ab94 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-0f79-0900000000-ff587935c79b4592ffcf | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-000i-1900000000-8a35d8a2241bc18d6c50 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-0006-9300000000-356a4b8f268863c7893e | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-0006-9000000000-a88c1004f357858fbc6c | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-014l-9000000000-271874005dcb90288512 | 2012-08-31 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - LC-ESI-QFT , negative | splash10-0udi-0900000000-cfa7e1cb9f02ffb4447d | 2017-09-14 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0udr-0900000000-4e409c6edda911de39fe | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-000i-1900000000-90aa0e0866454c2eacc7 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-1000-9400000000-210fd696305d8cf76164 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0udi-0900000000-ff95007680e484d3c57e | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0udi-1900000000-6dcfecebbd98220ef746 | 2017-06-28 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0kil-6900000000-f476cfd569c441bc84aa | 2017-06-28 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 661 |
|---|
| ChEMBL ID | CHEMBL59 |
|---|
| KEGG Compound ID | C03758 |
|---|
| Pubchem Compound ID | 681 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 18243 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | DB00988 |
|---|
| HMDB ID | HMDB00073 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HDV99-C:HDV99-C |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | 3-HYDROXYTYRAMINE|DOPAMINE |
|---|
| BIGG ID | 42467 |
|---|
| KNApSAcK ID | C00001408 |
|---|
| HET ID | LDP |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Dopamine |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Adrenergic | 37962 | An agent that stimulates the adrenergic nervous system, mimicking the effects of adrenaline. It plays a biological role in regulating heart rate, blood pressure, and energy. Therapeutically, adrenergic agents are used to treat conditions such as asthma, hypertension, and cardiac arrest, with key medical uses including bronchodilation, vasoconstriction, and increased cardiac output. | DUKE | | Anti lactagogue | | An agent that decreases milk production, used to suppress lactation in women, particularly after childbirth or abortion, or to treat conditions like galactorrhea (spontaneous milk flow). | DUKE | | Anti myocontractant | | An agent that relaxes smooth muscle, reducing muscle contractions. It has therapeutic applications in treating conditions like spasms, hypertension, and respiratory issues, with key medical uses including relieving asthma symptoms and managing gastrointestinal disorders. | DUKE | | Anti neurogenic | | An agent that impairs neural growth factor, inhibiting nerve growth and regeneration. It plays a biological role in reducing pain transmission and has therapeutic applications in managing chronic pain, cancer, and neurological disorders, with key medical uses including pain management and tumor treatment. | DUKE | | Anti-Parkinsonian | 48407 | An agent that alleviates symptoms of Parkinson's disease, enhancing dopamine levels and improving motor function, commonly used to manage tremors, rigidity, and bradykinesia in neurodegenerative disorders. | DUKE | | Anti prolactin | | An agent that inhibits prolactin production, a hormone regulating lactation and reproductive processes. Therapeutically, it's used to treat hyperprolactinemia, prolactinomas, and associated disorders, such as galactorrhea, infertility, and menstrual irregularities. | DUKE | | Anti-shock | | An agent that stabilizes blood pressure and circulation, reducing the effects of shock. Therapeutically, it's used to manage hypovolemic shock, anaphylactic shock, and septic shock, helping to prevent organ failure and promote recovery. Key medical uses include treatment of severe blood loss, burns, and trauma. | DUKE | | Anti-thyreotropic | | An antibody that inhibits thyrotropin, regulating thyroid hormone production. It has therapeutic applications in managing thyroid disorders, such as hyperthyroidism, and key medical uses include treating conditions like Graves' disease. | DUKE | | Cardiotonic | 38070 | An agent that strengthens heart muscle contractions, enhancing cardiac output. It plays a biological role in regulating heart function and is therapeutically used to treat heart failure, improving symptoms and exercise tolerance. Key medical uses include managing cardiomyopathy, atrial fibrillation, and congestive heart failure. | DUKE | | Diuretic | 35498 | An agent that increases urine production, helping remove excess fluids and salts from the body. It plays a key biological role in regulating fluid balance and blood pressure. Therapeutically, diuretics are used to treat conditions such as hypertension, edema, and heart failure, helping reduce swelling and lower blood pressure. | DUKE | | Hypertensive | | An agent that increases blood pressure, used therapeutically to treat hypotension (low blood pressure) and shock, and medically to manage conditions such as orthostatic hypotension and postural hypotension. | DUKE | | Inotropic | | An agent that alters the force or energy of muscular contractions, particularly in the heart. It has therapeutic applications in treating heart failure and cardiogenic shock. Positively inotropic agents, such as digoxin, increase contraction strength, while negatively inotropic agents, like beta blockers, weaken it, commonly used to manage arrhythmias and hypertension. | DUKE | | Myocontractant | | An agent that stimulates contractions of smooth muscle, playing a biological role in regulating muscle tone. Therapeutically, it has applications in treating conditions like uterine atony and gastrointestinal disorders. Key medical uses include inducing labor, managing postpartum hemorrhage, and treating gastrointestinal motility issues. | DUKE | | Natriuretic | | An agent that promotes the excretion of sodium in the urine, aiding in blood pressure regulation and fluid balance. It plays a biological role in managing hypertension and heart failure, with therapeutic applications in treating edema and cardiovascular diseases. Key medical uses include diuretic therapy and management of congestive heart failure. | DUKE | | Neurotransmitter | 25512 | A chemical messenger that transmits signals between neurons, regulating various physiological and psychological processes. Therapeutically, neurotransmitter modulators are used to treat conditions such as depression, anxiety, and Parkinson's disease, by altering neurotransmitter levels or activity to restore balance and alleviate symptoms. | DUKE | | Priapistic | | A condition characterized by persistent, usually painful erection of the penis, often due to disease. It has no direct therapeutic applications, but treatments for priapism include medications to reduce erection, such as phenylephrine, and are used to manage conditions like sickle cell disease, leukemia, and erectile dysfunction. | DUKE | | Sympathomimetic | 35524 | An agent that mimics the effects of the sympathetic nervous system, increasing heart rate, blood pressure, and energy. Therapeutically, it's used to treat conditions like asthma, hypotension, and shock, as well as nasal decongestion and eye dilation. | DUKE | | Teratogenic | 50905 | An agent that causes abnormal fetal development, disrupting embryonic growth and leading to birth defects. Its biological role is associated with developmental toxicity, and it has no therapeutic applications. Key medical uses include serving as a warning for substances that pose risks during pregnancy, guiding prenatal care and medication management to prevent birth defects. | DUKE | | Vasoconstrictor | 50514 | An agent that narrows blood vessels, reducing blood flow. It plays a biological role in regulating blood pressure and is therapeutically used to treat conditions like hypotension, nasal congestion, and bleeding. Key medical uses include managing shock, reducing bleeding during surgery, and relieving migraine headaches. | DUKE | | Vasodilator | 35620 | An agent that widens blood vessels, reducing blood pressure and increasing blood flow. It plays a biological role in regulating cardiovascular function. Therapeutically, vasodilators are used to treat conditions such as hypertension, angina, and heart failure, improving oxygen delivery and reducing cardiac workload. | DUKE | | Dopaminergic | 48560 | An agent that stimulates or regulates dopamine activity, playing a key role in movement, motivation, and reward processing. Therapeutically, dopaminergic agents are used to manage Parkinson's disease, restless leg syndrome, and certain psychiatric disorders, such as schizophrenia and depression. | CHEBI |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Aromatic-L-amino-acid decarboxylase | DDC | P20711 | | D(2) dopamine receptor | DRD2 | P14416 | | D(4) dopamine receptor | DRD4 | P21917 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|